The pathway enables a multifaceted diabetes intervention by simultaneously improving insulin signaling (AMPK‐dependent), normalizing metabolic flux (SIRT1‐mediated), and restoring mitochondrial function (PGC‐1α‐driven). This evidence concerns the gene PRKAA2 and diabetes mellitus.